Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Infertility drugs industry 3600 synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Drug class trends
2.1.4 Route of administration trends
2.1.5 Gender trends
2.1.6 Distribution channel trends
Chapter 3 Infertility Drugs Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of infertility worldwide
3.2.1.2 Rising healthcare awareness along with increasing aging female population
3.2.1.3 Increasing funding for infertility R&D
3.2.2 Industry pitfalls & challenges
3.2.2.1 Side effects and risks associated with infertility drugs
3.3 Growth potential analysis
3.3.1 By drug class
3.3.2 By route of administration
3.3.3 By gender
3.3.4 By distribution channel
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Infertility Drugs Market Size and Forecast, By Drug Class (USD Million)
5.1 Key trends, by drug class
5.2 Gonadotropins
5.3 Aromatase Inhibitors
5.4 Selective Estrogen Receptor Modulators (SERMs)
5.5 Dopamine Agonists
5.6 Other drug classes
Chapter 6 Infertility Drugs Market Size and Forecast, By Route of Administration (USD Million)
6.1 Key trends, by route of administration
6.2 Oral
6.3 Parenteral
6.4 Topical
Chapter 7 Infertility Drugs Market Size and Forecast, By Gender (USD Million)
7.1 Key trends, by gender
7.2 Female
7.3 Male
Chapter 8 Infertility Drugs Market Size and Forecast, By Distribution Channel (USD Million)
8.1 Key trends, by distribution channel
8.2 Hospital Pharmacies
8.3 Specialty & Retail Pharmacies
8.4 Online Pharmacies
Chapter 9 Infertility Drugs Market Size and Forecast, By Region (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 MEA
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of MEA
Chapter 10 Company Profiles
10.1 Merck KGaA
10.2 Ferring B.V.
10.3 Abbott
10.4 Livzon
10.5 Pfizer Inc.
10.6 Mankind Pharma
10.7 Teva Pharmaceutical Industries Ltd.
10.8 IBSA Institut Biochimique SA
10.9 Besins Healthcare
10.10 Organon Group of Companies
10.11 Novartis International AG
